NHF therapy
- Business Wire
Study Investigates the Ability of Masimo PVi® to Predict Preload Responsiveness in Patients On Nasal High-Flow Therapy
Researchers Found That PVi May Be Used to Guide Fluid Administration in Nasal High-Flow Patients NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI)…
Read More »